RYTCX
Price
$7.78
Change
-$0.15 (-1.89%)
Updated
Feb 3 closing price
Net Assets
943.53M
UBVVX
Price
$82.18
Change
-$2.64 (-3.11%)
Updated
Feb 3 closing price
Net Assets
8.97B
Interact to see
Advertisement

RYTCX vs UBVVX

Header iconRYTCX vs UBVVX Comparison
Open Charts RYTCX vs UBVVXBanner chart's image
Royce Small-Cap Total Return Consult
Price$7.78
Change-$0.15 (-1.89%)
VolumeN/A
Net Assets943.53M
Undiscovered Managers Behavioral Val R5
Price$82.18
Change-$2.64 (-3.11%)
VolumeN/A
Net Assets8.97B
RYTCX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
RYTCX vs. UBVVX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYTCX is a Buy and UBVVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 8.97B vs. RYTCX (944M). UBVVX pays higher dividends than RYTCX: UBVVX (1.73) vs RYTCX (0.12). RYTCX was incepted earlier than UBVVX: RYTCX (24 years) vs UBVVX (9 years). RYTCX (2.24) is less costly to investors than UBVVX (0.94). RYTCX is a more actively managed with annual turnover of: 51.00 vs. UBVVX (35.00). UBVVX has a lower initial minimum investment than RYTCX: UBVVX (0) vs RYTCX (2000). UBVVX annual gain was more profitable for investors over the last year : -1.54 vs. RYTCX (-3.83). UBVVX return over 5 years is better than : 25.41 vs. RYTCX (-22.33).
RYTCXUBVVXRYTCX / UBVVX
Total Expense Ratio2.240.90249%
Annual Report Gross Expense Ratio2.240.94238%
Fund Existence24 years9 years-
Gain YTD5.9955.130117%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets944M8.97B11%
Annual Yield % from dividends0.121.737%
Returns for 1 year-3.83-1.54249%
Returns for 3 years2.054.9442%
Returns for 5 years-22.3325.41-88%
Returns for 10 years-28.55N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAZE47.971.44
+3.09%
Maze Therapeutics Inc
CARE21.930.08
+0.37%
Carter Bankshares
IMA7.04-0.05
-0.71%
ImageneBio Inc
CRCL56.16-2.70
-4.59%
Circle Internet Group Inc
IBG4.05-0.33
-7.44%
Innovation Beverage Group Limited